Table 3—

Regression analysis of delay in initiating insulin treatment

VariablePhysicians
Nurses
Unstandardized coefficientStandardized coefficientUnstandardized coefficientStandardized coefficient
Australia−0.498*−0.084−0.504−0.080
France−0.604*−0.102−0.118−0.019
Germany−0.476*−0.080−0.322−0.052
India0.009§0.0020.4550.072
Japan−0.208−0.034−0.247−0.037
Netherlands−0.776*−0.131−0.157−0.026
Poland−1.037*−0.174−0.015§0.002
Scandinavia−1.097*−0.181−1.050*−0.169
Spain−0.296−0.050−0.137§−0.021
U.K.−0.489*−0.082−0.562−0.092
Population density0.0360.024−0.034§−0.022
Age0.0040.021−0.001−0.004
Sex0.0220.006−0.075−0.009
Percent with type 2 diabetes0.0740.008−0.503−0.056
Years of practice0.000−0.0020.0010.005
Specialist−0.372*−0.091−0.258−0.072
Opinion leader−0.518*−0.084−0.325−0.047
Medication adherence0.1400.045NSNS
Appointment adherenceNSNS0.1330.042
Delay oral medication0.475*0.4760.626*0.602
Insulin efficacy−0.143*−0.133−0.110*−0.093
Model R20.3350.535
  • The U.S. is the reference category for countries; country coefficients are interpreted as differences from the U.S. Mean substitution used for missing values.

  • *

    * P < 0.001;

  • P < 0.01;

  • P < 0.10;

  • §

    § P < 0.05 at entry;

  • P < 0.05. NS, not significant.